Proficimus More Irretenti. 🇮🇱 iapps.courts.state.ny.us/nys…

Joined February 2020
1,450 Photos and videos
The Great Wall, 6/14/26
2
28
Owen Scottt Muir, MD, DFAACAP, FCTMSS retweeted
The psychiatric system is finally catching up. The New York Times reports that top US psychiatrists are now developing formal guidance for safely coming off antidepressants, something Outro has been doing all along. Read the full article via the link in our bio! @markhoro
4
18
55
9,492
Owen Scottt Muir, MD, DFAACAP, FCTMSS retweeted
Meds don't treat autism's core symptoms, but TMS brings hope in new trial: psych-partners.com/tms-in-au… Earlier studies were mixed, but this used fMRI to direct magnet more accurately, targeting the fronto-parietal network with iTBS.
3
15
56
3,137
Owen Scottt Muir, MD, DFAACAP, FCTMSS retweeted
Clinical breakthrough: TMS therapy shows 60-70% improvement rates in treatment-resistant depression. This non-invasive approach offers evidence-based hope when trad... #TMStherapy #depressionresearch #mentalhealthbreakthrough #evidencebased #neuroscience drgabbyfarkas.com/?p=6434
1
4
173
After having seen all those posts to people posting dermatologic conditions and asking the audience of this platform to guess what the problem is, I'm both amused and disheartened. Can you imagine doing this for psychiatry? * i get that it's an engagement bait.*
102
You can learn how to use Claude by asking Claude how to use Claude. I've just saved you the trouble of paying an influencer for their course. You can also ask Claude how to use Claude code. You can also ask Claude how to use Claude cowork. Smash like and subscribe ;)
1
5
136
Owen Scottt Muir, MD, DFAACAP, FCTMSS retweeted
Among adults with #TreatmentResistantDepression, single-day inhaled GH001 resulted in rapid, significant symptom reduction and remission vs placebo, with no severe adverse events and sustained effects over 6 months. ja.ma/4uOWSK1
4
35
111
24,122
Owen Scottt Muir, MD, DFAACAP, FCTMSS retweeted
Emerging evidence supports 5-MeO-DMT as a promising, ultra-short-acting psychedelic for treatment-resistant depression and other psychiatric conditions, warranting larger randomized controlled trials. journals.lww.com/americanthe…
7
18
80
2,220